Summary
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
History
Suven Life Sciences was established in 1990 as Venkatdescription, a proprietary research and development company. In 1995, the company changed its name to Suven Pharmaceuticals and obtained a public limited company status in 2000. Since then, Suven has grown to become a market leader in specialty pharmaceuticals, with a presence in more than 30 countries
Mission
Our mission is to be the leading provider of life sciences products and solutions, enabling our customers to improve the quality of life, prevent and cure diseases, and reduce the cost of health care.
Vision
Our vision is to be a world-class, integrated life sciences company providing innovative solutions and superior performance to our customers.
Key Team
Mr. Shrenik Soni C.S. (Company Sec. & Compliance Officer)
Ms. Kalyani Jasti (Pres of US Operations)
Recognition and Awards
Suven Life Sciences is the recipient of several awards and accolades, including the prestigious ‘Maharashtra Innovation Award’ for its innovative approach to research, development, and manufacturing.
References
